Evidence map›Paper›PMID 24419110›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Combination chemoradiation therapy: the whole is more than the sum of the parts.

Harvey J Mamon, Joel E Tepper

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03680261 (Phase III Multicenter Randomized Controlled Trial of Adjuvant Chemoradiotherapy vs Chemotherapy for Radical Resected Advanced Gastric Carcinoma Concurrent With Lymph Node Metastasis and Lymphovascular Invasion), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03680261 phase3unknown statusnot on this mapstarted 2018, after this paper: background citation

Phase III Multicenter Randomized Controlled Trial of Adjuvant Chemoradiotherapy vs Chemotherapy for Radical Resected Advanced Gastric Carcinoma Concurrent With Lymph Node Metastasis and Lymphovascular Invasion

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2018 to 2023Enrolled556ConditionsGastric CancerArmschemoradiotherapy, chemotherapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Design, Synthesis, and Cytotoxicity Assessment of [Nanomaterials (Basel, Switzerland) · 2021
    Article
  2. Article
  3. Chemophototherapy: An Emerging Treatment Option for Solid Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2017
    Review
  4. Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2016
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Harvey J MamonDana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA.
Joel E Tepper

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemotherapy, AdjuvantEsophagectomyEsophagogastric JunctionNeoadjuvant TherapyAdenocarcinomaCarcinoma, Squamous CellEsophageal NeoplasmsFemaleGastrectomyHumansMaleNeoplasm Recurrence, LocalStomach Neoplasms

Identifiers

PMID24419110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.